Newborn
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Newborns of both sexes; aged between 24 and 48 hours of life; with gestational age between 37 weeks and 41 weeks and 6 days; and birth weight between 2,500 g and 3,999 g.
Exclusion criteria
Exclusion criteria: Newborns with congenital malformations perceptible on physical examination or reported by the mother; jaundice in the first 24 hours of life; ABO and/or Rh incompatibility; family history of a sibling treated with phototherapy for neonatal jaundice; Asian descent; or the presence of cephalohematoma or ecchymoses, since these conditions constitute risk factors for significant hyperbilirubinemia in neonates with a gestational age greater than 35 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to evaluate the reduction of bilirubin levels in newborns; verified through standardized clinical assessment (Kramer scale); the outcome will be considered as the decrease in bilirubin levels and/or the absence of need for therapeutic interventions, such as phototherapy or exchange transfusion, according to established clinical guidelines. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to evaluate newborn weight gain; verified through weight measurement using a calibrated scale at defined time points (at birth, between 24 and 48 hours, and on the 7th day of life); the outcome will be considered as the variation in weight in grams between the evaluated time points, including recovery of birth weight or adequate weight gain according to neonatal parameters. | — |
Countries
BR
Contacts
Universidade Federal do Piauí